Nexvet Biopharma plc 4
4 · Nexvet Biopharma plc · Filed Sep 7, 2016
Insider Transaction Report
Form 4
PATEL RAJIV A
Director10% OwnerOther
Transactions
- Award
Restricted Share Units
2016-09-05+3,600→ 6,600 totalExercise: $0.13From: 2017-07-01Exp: 2021-07-01→ Ordinary Shares (3,600 underlying)
Footnotes (3)
- [F1]Each Restricted Share Unit ("RSU") is convertible into one ordinary share of the Issuer upon vesting, subject to payment by the holder to the Issuer of the nominal value per share ($0.125) within 30 days of vesting.
- [F2]On September 5, 2016, the Issuer awarded 3,600 RSUs to Rajiv A. Patel ("Patel"), pursuant to the Issuer's 2015 Equity Incentive Plan. Such 3,600 RSUs will vest and become convertible on July 1, 2017.
- [F3]The remaining 3,000 RSUs held by Patel will vest and become convertible in quarterly installments of 500, beginning September 30, 2016 and ending December 31, 2017.